GLPwatch
Bydureon for Opioid use disorder
exenatide · Investigational / off-label
Last updated 2026-05-28 15:46 UTCBydureon (exenatide) is not FDA-approved for opioid use disorder, and any use for this condition is off-label or investigational. The listed research examines exenatide's effects on cocaine use disorder, not opioid use disorder.
AI summary of the sources below.
| Drug | Bydureon (exenatide) |
|---|---|
| Condition | Opioid use disorder |
| Approval status | Investigational / off-label |
| Research papers | 2 |
Bydureon is not FDA-approved for opioid use disorder; the research below reflects investigational or off-label study only.